W*USA 9 |
Novo touts one-year data for its diabetes tandem therapy
FierceBiotech Combine the blockbuster GLP-1 drug Victoza with a long-acting insulin and you get a treatment greater than the sum of its parts, according to Novo Nordisk ($NVO), which unveiled promising new data on its diabetes cocktail IDegLira. In a 52-week study … Sanofi, Medtronic Form Diabetes AllianceWall Street Journal Sanofi, Medtronic join on diabetes drugs, devicesW*USA 9 Medtronic, Sanofi Join On Diabetes Drugs, DevicesCBS Local GlobeNewswire (press release) all 105 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.